Brand Prices Increase More When Authorized Generics Launch – GPhA Study
Executive Summary
A study commissioned by the Generic Pharmaceutical Association found that brand prices increased more when an "authorized" generic is launched during the first generic's 180-day exclusivity period
You may also be interested in...
Authorized Generics: FTC Study May Get Jumpstart; PhRMA Paper Finds No Harm
The Federal Trade Commission's study on the impact of authorized generics could be enhanced under an amendment to the legislation reauthorizing the FDA's Rx user fee program
Authorized Generics: FTC Study May Get Jumpstart; PhRMA Paper Finds No Harm
The Federal Trade Commission's study on the impact of authorized generics could be enhanced under an amendment to the legislation reauthorizing the FDA's Rx user fee program
FTC Commissioner Urges Generic Firms To Shun Reverse Payment Deals
The generic industry should refrain from entering into settlement agreements with brand companies that involve payments to keep generics off the market, Federal Trade Commissioner Jon Leibowitz said at the Generic Pharmaceutical Association's Annual Policy Conference in Washington, D.C. Sept. 19